Longevity Health Holdings Inc. (XAGE) Financial Ratios
4 years of historical data (2021–2024) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: 95.93
30Y Low95.9·High95.9
ROE
↓
-103.5%
↑-25% vs avg
5yr avg: -83.0%
30Y Low-103%·High-62%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XAGE Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Longevity Health Holdings Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $7M | $175M | $2.4B | $5.9B | $5.7B |
| Enterprise Value | $7M | $175M | $2.4B | $5.9B | $5.7B |
| P/E Ratio → | -0.64 | — | — | — | — |
| P/S Ratio | 133.03 | 3477.45 | — | — | — |
| P/B Ratio | — | — | 95.93 | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
XAGE EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 3487.02 | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | — | — | — | — |
XAGE Profitability
Margins and return-on-capital ratios measuring operating efficiency
Longevity Health Holdings Inc. earns an operating margin of -9933.8%. A negative ROE of -103.5% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 87.4% | 87.4% | — | — | — |
| Operating Margin | -9933.8% | -9933.8% | — | — | — |
| Net Profit Margin | -20605.5% | -20605.5% | — | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | -103.5% | -103.5% | -62.4% | — | — |
| ROA | -31.7% | -31.7% | -47.0% | -547.6% | -416.1% |
| ROIC | -38.0% | -38.0% | — | — | — |
| ROCE | -47.5% | -47.5% | -52.4% | — | — |
XAGE Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $481854 ($638993 total debt minus $157139 cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.09 | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | — | -0.03 | — | — |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — |
| Interest Coverage | -101.98 | -101.98 | -5.87 | -1.47 | -0.19 |
XAGE Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.16x is below 1.0, meaning current liabilities exceed current assets. The current ratio has improved from 0.08x to 0.16x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 0.16 | 0.16 | 1.63 | 0.08 | 0.01 |
| Quick Ratio | 0.14 | 0.14 | 1.63 | 0.08 | 0.01 |
| Cash Ratio | 0.03 | 0.03 | 0.08 | 0.02 | 0.05 |
| Asset Turnover | — | 0.03 | — | — | — |
| Inventory Turnover | 0.06 | 0.06 | — | — | — |
| Days Sales Outstanding | — | 2219.20 | — | — | — |
XAGE Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Longevity Health Holdings Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $21M | $21M | $20M | $20M |
Peer Comparison
Compare XAGE with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XAGEYou | $7M | -0.6 | — | — | 87.4% | -9933.8% | -103.5% | -38.0% | — |
 HIMS | $7B | 50.3 | 42.7 | 89.6 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 MGRX | $6M | -0.1 | — | — | 61.7% | -1294.4% | -118.3% | -83.8% | — |
 WELL | $149B | 153.3 | 66.4 | 52.4 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 GDRX | $973M | 33.3 | 4.0 | 5.9 | 82.1% | 13.4% | 4.5% | 13.0% | 0.3 |
 TALK | $868M | 129.5 | 137.8 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 AMWL | $129M | -1.3 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 TDOC | $1B | -6.1 | 15.1 | 4.4 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 OPRX | $124M | 24.6 | 6.5 | 6.6 | 67.3% | 10.7% | 4.2% | 7.1% | 0.3 |
 DOCS | $5B | 23.5 | 21.1 | 19.6 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 |
 CVS | $111B | 62.8 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
See XAGE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XAGE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XAGE vs HIMS
Side-by-side business, growth, and profitability comparison vs Hims & Hers Health, Inc..
Start ComparisonXAGE — Frequently Asked Questions
Quick answers to the most common questions about buying XAGE stock.
What is Longevity Health Holdings Inc.'s P/E ratio?
Longevity Health Holdings Inc.'s current P/E ratio is -0.6x. This places it at the 50th percentile of its historical range.
What is Longevity Health Holdings Inc.'s ROE?
Longevity Health Holdings Inc.'s return on equity (ROE) is -103.5%. The historical average is -83.0%.
Is XAGE stock overvalued?
Based on historical data, Longevity Health Holdings Inc. is trading at a P/E of -0.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Longevity Health Holdings Inc.'s profit margins?
Longevity Health Holdings Inc. has 87.4% gross margin and -9933.8% operating margin.